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Abstract
Background: Friedreich ataxia originates from a decrease in mitochondrial frataxin, which causes the death of a subset of
neurons. The biochemical hallmarks of the disease include low activity of the iron sulfur cluster-containing proteins (ISP) and
impairment of antioxidant defense mechanisms that may play a major role in disease progression.
Methodology/Principal Findings: We thus investigated signaling pathways involved in antioxidant defense mechanisms.
We showed that cultured fibroblasts from patients with Friedreich ataxia exhibited hypersensitivity to oxidative insults
because of an impairment in the Nrf2 signaling pathway, which led to faulty induction of antioxidant enzymes. This
impairment originated from previously reported actin remodeling by hydrogen peroxide.
Conclusions/Significance: Thus, the defective machinery for ISP synthesis by causing mitochondrial iron dysmetabolism
increases hydrogen peroxide production that accounts for the increased susceptibility to oxidative stress.
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Introduction
Mitochondria are the main site of molecular oxygen utilization in
cells. The divalent reduction of oxygen by the respiratory chain is
tightly coupled to ATP synthesis by the oxidative phosphorylation
machinery [1]. However, monovalent reduction of a small
proportion of the available oxygen, which produces superoxide
anions, occurs in association with the transfer of electrons through
the respiratory chain [2]. During this process, superoxides may be
released on both sides of the inner mitochondrial membrane,
depending on their production sites [3]. They are subsequently
handled by the superoxide dismutases (SODs) present in mitochon-
dria (manganese-dependent SOD in the matrix compartment and
copper, zinc-dependent SOD in the intermembrane compartment)
[4]. Under basal conditions, progression through the cell cycle is
dependent on superoxide production [5]. However, overproduction
of superoxides due to abnormal reduction of key components of the
respiratory chain (i.e., ubiquinone and cytochrome b)o rt o
impairment of antioxidant defenses adversely affects various cellular
processes and constituents [2]. Disturbances in either respiratory
chain or cellular defenses are being incriminated in an increasing
numberofacquiredand inheriteddiseases[6].Inthisstudy,weused
Friedreich ataxia (FRDA) as a paradigm to investigate the
mechanisms involved in impaired cellular responses to mitochon-
drialoxidativeinsults.The increasedsusceptibilitytooxidativestress
that characterizes FRDA has been documented both in vitro [7] and
in vivo [8,9,10]. Progression of the cardiac hypertrophy and of some
of the neurological disorders can be slowed by treatment with
idebenone, a short-chain ubiquinone homologue with potent
antioxidant properties [11,12].
FRDA is a neurodegenerative condition responsible for cerebellar
ataxia and life-threatening cardiomyopathy. Glucose intolerance or
diabetes develops in some patients [13]. More than 95% of patients
are homozygous for large expansions (60 to 2000) of a GAA triplet–
repeat sequence within the first intron of the gene for frataxin, a 210–
amino acid protein found in the mitochondrial matrix [14]. The
expansion impedes the transcription of the gene and reduces frataxin
levels to a few percentage points of normal [15]. Affected tissues are
deficient in iron-sulfur cluster (ISC) proteins [16], whose assembly is
impaired as a result of inadequate handling of iron [17,18]. ISC
deficiency results in profound deficiencies in the mitochondrial
respiratory chain complexes I, II, and III and of the Krebs cycle
enzyme aconitase, all of which require ISCs for electron transfer
catalysis [16]. Since ISCs synthesized in the mitochondria are
subsequently distributed to the various cell compartments [19], the
deficiency is not restricted to mitochondrial enzymes but instead
affects non-mitochondrial proteins also.
Several tissues (e.g., skeletal muscle) and cells (e.g., skin
fibroblasts and circulating lymphocytes) seem able to cope with
low frataxin levels and to synthesize enough ISCs to ensure normal
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4253production of respiratory chain complexes and aconitase [16].
Nevertheless, fibroblasts from patients with FRDA have impaired
responses to oxidative insults, whether endogenous (mitochondrial
ATPase blockade by oligomycin) [7] or exogenous (added
hydrogen peroxide) [20]. FRDA fibroblasts exhibit actin stress
fiber abnormalities [21] and are deficient in glutathione [22].
Previous attempts to determine why these cells are hypersensitive
to oxidative stress were unsuccessful. Faulty NF-KB-dependent
signaling of antioxidant defenses was ruled out [23]. We recently
established that human fibroblasts harboring the ATPase 6 NARP
mutation activated the Nrf2-dependent Phase II antioxidant
pathway [24]. Under basal conditions, the transcription factor
Nrf2 (nuclear factor-erythroid 2-related factor 2) is sequestered in
the cytosol, where its Neh2 domain binds to the Kelch domain of
the Keap1 protein tethered to actin bundles [25]. These bundles,
called actin stress fibers, are found in the center of the cytoplasm
and periphery of the nucleus. Cul3-dependent ubiquitination of
Nrf2 leads to degradation by the proteasome [26]. When oxidative
modification of one of the Keap1 cysteines occurs, Nrf2 escapes
from this proteolytic pathway. Phosphorylated Nrf2 then translo-
cates to the nucleus, where it dimerizes with a small Maf protein
and binds to the cis-acting antioxidant responsive element (ARE)
DNA sequences of Phase II antioxidant genes, activating their
transcription [13]. These genes encode the SODs, catalase,
glutathione, glutathione reductase (GRed), glutathione-S-transfer-
ase (GST), glutamate-cysteine ligase catalytic subunit (GCLC), and
NADH quinone oxidoreductase 1 (NQO1) [27,28].
Here, we investigated the mechanism underlying the increased
sensitivity to oxidative stress of frataxin-depleted cells (cultured
fibroblasts from patients with FRDA and neuroblastomata-derived
SKNAS cells). The Nrf2-dependent signaling pathway was found
to be defective. The phenotype associated with the Nrf2-signaling
defect was corrected by the catalase mimetic Euk134, emphasizing
the key role for the cellular hydrogen peroxide content.
Results
Increased sensitivity of FRDA cultured fibroblasts to
oxidative stress
SOD levels were moderately but consistently elevated and GSH
levels were decreased in severely frataxin-depleted FRDA cultured
fibroblasts under basal culture conditions, indicating abnormally
high antioxidant activity (Table 1). Cell respiration was normal, and
oxidative activity was tightly controlled by the phosphorylation
process (Figure 1b). No decreases were found in the activities of the
respiratory chain complexes (CI to CV). There was no superoxide
overproduction by the respiratory chain, as indicated by the
antimycin-resistantcytochrome creductaseactivitymeasuredunder
highly reducing conditions (not shown). Aconitase, an ISC-
containing enzyme whose activity is diminished in affected tissues
(heart and brain) from FRDA patients, showed similar levels of
activity in FRDA and control fibroblasts. Finally, we investigated
the glutaredoxin 2 (Grx2) protein, which contains an ISC and
protects against oxidative damage by helping to maintain
glutathione homeostasis. The ISC stabilizes an inactive form of
Grx2, which becomes active upon oxidative disruption of the ISC
[29,30]. We found no significant changes in the Grx2 expression
profile betweenFRDA and controlfibroblasts (Supplemental Figure
S1 and Supplemental Text S1 for experimental conditions).
Whereas FRDA fibroblasts proliferate normally under basal
conditions, they are oversensitive to the endogenous oxidative
insult that results from oligomycin-induced blockade of mitochon-
drial ATPase [31] (Figure 1A). Similarly, frataxin-depleted cells
are oversensitive to endogenous and exogenous oxidative insults
[20,32]. We and others have ascribed this increased sensitivity to
impaired induction of antioxidant enzymes in response to
oxidative stress [7,23].
Abnormal location of the Nrf2 transcription factor in
FRDA cultured fibroblasts
Transcription of inducible antioxidants is controlled chiefly by
the Nrf2 transcription factor [27,33]. We found that Nrf2 in
control cells was bound to phalloidin-reactive actin stress fibers
(Figure 1Ca and b), which also tethered the redox-sensitive Keap-1
protein (Figure 1Cc). In contrast, Nrf2 was not associated with any
filamentous structures in FRDA fibroblasts (Figure 1Cd), whose
actin stress fibers were abnormally distributed (Figure 1Ce), being
found mainly in the cell periphery as previously reported [21].
Finally, Keap1 was not associated with actin stress fibers in FRDA
fibroblasts (Figure 1Cf).
Nrf2 fails to translocate to FRDA cultured fibroblast
nuclei in response to oxidative stress
Oligomycin or tBHQ was used to induce endogenous or
exogenous oxidative stress, respectively. Oligomycin inhibits the
enzyme ATPase, thus causing over reduction of the mitochondrial
quinone pool, which in turn leads to superoxide overproduction
[34]; tBHQ undergoes redox cycling either by cellular quinone
reductases or via autooxidation reactions, the main end product
being hydrogen peroxide [35]. Upon exposure to oligomycin or
tBHQ, Nrf2 in control cells was released from the actin stress fibers
then translocated chiefly to the nuclei (Figure 2A a–c). Nuclear
translocation of Nrf2 in FRDA fibroblasts did not occur (Figure 2A
d–f). Interestingly enough, neither activation of the Phosphatidyl
Inositol 3 kinase (PI3 kinase) by compound 48/80 (2 mg/ml) [36]
nor Protein Kinase C (PKC) by phorbol 12-myristate 13-acetate
(5 mg/ml) [37] did restore the capacity of a Nrf2 nuclear
translocation in FRDA fibroblasts upon an oxidative stress
(oligomycin treatment; not shown).
Next, we performed Western blot analyses of nuclei-enriched
fractions and cytoplasmic fractions of control and FRDA fibroblasts
(Figure 2B). In the cytoplasmic fractions of control and FRDA
fibroblasts, Nrf2 content increased 2-fold to 4-fold in response to
oligomycin or tBHQ (Figure 2B). In the nuclei-enriched fraction of
control cells, Nrf2 increased 4-fold in response to oligomycin and 8-
fold in response to tBHQ. Far smaller Nrf2 increases were seen in
the nuclei-enriched fractions of FRDA cells (Figure 2C).
Decreased expression of Nrf2-targeted genes in FRDA
cultured fibroblasts
The failure of Nrf2 to translocate to the nucleus in FRDA cells
exposed to oxidative stress prompted us to investigate the expression
Table 1. Chronic abnormal redox status in fibroblasts from
patients with Friedreich ataxia.
Frataxin
mRNA (% of
controls)
Superoxide
dismutase
activity (IU/mg
prot)
Total
glutathione
(nmol/mg)
GSH/
GSSG
Ratio
Controls (n=3) 105.266.5 *** 41.168.6 94.6614.8 5.961.5 *
Patients (n=4) 15.1610.2 *** 61.2613.1 99.0623.2 2.460.7 *
Experimental conditions as described in the methods section.
*p,0.05 and
***p,0.001 respectively.
doi:10.1371/journal.pone.0004253.t001
Faulty Nrf2 Signaling in FRDA
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greater than 10-fold increases in catalase and glutathione-S-
transferase subunit 1 (GSTP1) transcripts, a 5-fold increase in
NADH quinone oxidoreductase (NQO1) transcript, and virtually no
increases in copper-zinc (Sod1)- or manganese (Sod2)-dependent
SOD transcripts (Figure 3A). In FRDA cells, the increases were far
smaller; most notably, neither catalase nor GSTP1 transcripts
increased noticeably in response to tBHQ. Oligomycin treatment of
control cells caused large increases in Sod2, catalase, and GSTP1
transcripts; whereas Sod1 and NQO1 transcripts were not
substantiallyincreased (Figure 3B). None ofthesephase II antioxidant
enzymes increased in FRDA cells exposed to oligomycin.
Figure 1. Effect of frataxin depletion on oxidative stress resistance, oxidative properties, and actin-Nrf2 signaling pathway status
in cultured skin fibroblasts. A. Sensitivity of control and patient cells to oligomycin (30 mM for 4 days). Cells were harvested at 24-hour intervals
and live cells were counted. The proportion of surviving cells was significantly different between controls and patients (ANOVA p,0.01). Significant
differences were noted (**p,0.01 and ***p,0.001). Values are means61 SEM. Open and dark symbols represent control and patient cells,
respectively. Filled squares represent patients. B. Effect of frataxin depletion on cell oxidative properties. Under basal conditions, respiration rates
were similar between fibroblasts from controls and patients. Adding oligomycin caused greater than 80% inhibition in both cell types. Uncoupled
respiration measured in the presence of m-Cl-CCP (carbonyl cyanide m-chlorophenylhydrazone) decreased progressively when digitonin was added
to induce cell permeabilization. Malonate-sensitive mitochondrial succinate oxidation was not different between control and patient cells. Numbers
along the traces are nmol/min/mg protein. C. Nrf2/Keap1 localization in patient and control fibroblasts. Labeling of Nrf2, actin (Phal), and Keap1
proteins in control (a, b, c) and patient (e, f, g) fibroblasts, showing disorganization of the actin network and abnormal location of Nrf2 and Keap1 in
patient fibroblasts. Experimental procedures are described in the methods section.
doi:10.1371/journal.pone.0004253.g001
Faulty Nrf2 Signaling in FRDA
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phenotype
The disruption of the Nrf2-signaling pathway in FRDA
fibroblasts suggested a mechanism for the hypersensitivity of
frataxin-depleted cells to oxidative stress. However, neurons, not
fibroblasts, are selectively targeted in Friedreich ataxia. Therefore,
we studied neuroblastoma-derived cell lines (SKNAS), using
shRNA to silence frataxin. Immunohistochemistry showed severe
frataxin-protein depletion in shRNA-treated cells (Figure 4A). The
amount of frataxin in these cells was similar to that in FRDA
fibroblasts (Figure 4B).
Next, we investigated the organization of actin stress fibers and
the location of Nrf2 under basal conditions in SKNAS cells
(Figure 4C). Actin stress fibers were visualized by phalloidin
labeling in SKNAS cells under basal conditions (Figure 4Ca). Nrf2
labeling, in contrast, did not show the filamentous structures
observed in fibroblasts. Frataxin-depleted SKNAS cells exhibited
actin network reorganization similar to that observed in fibroblasts
(Figure 4Cb). After Nrf2 staining, they were nearly identical to
control SKNAS cells (Figure 4Cc and d).
We used tBHQ to induce oxidative stress of SKNAS cells.
Nuclear translocation of Nrf2 occurred with control SKNAS cells
(Figure 4Ce and g) but not frataxin-depleted SKNAS cells
(Figure 4Cf and h). Similar results were obtained when control
and frataxin-depleted SKNAS cells were treated with oligomycin
(not shown). Thus, as with FRDA fibroblasts, frataxin depletion
Figure 2. Nrf2 location and amount in control and FRDA patient fibroblasts under basal and oxidative stress conditions. A. Nrf2
localization in control (a, b, c) and patient (d, e, f) fibroblasts under basal conditions (a, d) or after treatment with oligomycin (b, e) or tBHQ (c, f).
Nuclear Nrf2 translocation occurred in control cells, but not patient cells, after oligomycin or tBHQ treatment. B. Western blots of cytoplasmic (a;
40 mg/lane protein) and nuclear (b; 60 mg/lane protein) fractions from control (lanes 1–3) and patient (lanes 4–6) fibroblasts under basal conditions
(lane 1, 4), after oligomycin treatment (lane 2, 5), or after tBHQ treatment (lane 3, 6). The specificity of the 100 kDa band was confirmed using two
antibodies (H-300 and C-20). Fraction purity (d) was assessed by labeling with GAPDH (cytoplasm) and Histone H1 antibody (nuclei). C. Nrf2 content
relative to GAPDH and Histone H1 contents in cytoplasmic and nuclear fractions of control and patient fibroblasts. Asterisks denote significant
differences (*p,0.05 and **p,0.01). Values are means61 SEM. Experimental procedures are described in the methods section.
doi:10.1371/journal.pone.0004253.g002
Faulty Nrf2 Signaling in FRDA
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SKNAS cells.
Finally, we investigated whether the transcription of Nrf2-
targeted genes was impaired in frataxin-depleted SKNAS cells
exposed to oxidative stress. Treating control SKNAS cells by
oligomycin (Figure 4Da) or tBHQ (Figure 4Db) resulted in the
accumulation of NQO1, glutathione reductase (GRed) and
GSTP1, to variable degrees. None of these transcripts increased
in frataxin-depleted SKNAS cells exposed to oxidative stress.
A catalase mimetic restores the Nrf2 response to
oxidative stress
Our finding that frataxin-depleted FRDA fibroblasts exhibited a
small but consistent increase in peroxide production, in keeping
with the higher basal level of SOD (Table 1) led us to investigate
the effects of correcting the increased peroxide levels via treatment
with the catalase mimetic Euk134. Euk134 is derived from a
compound with SOD activity that has been modified to obtain
strong catalase activity [38]. Euk134 diffuses freely through the
plasma membrane. Euk134 treatment of frataxin-depleted fibro-
blasts for 24 hours restored the actin stress fibers (Figure 5A a and
b) and relocated Nrf2 to the actin filament network (Figure 5A c
and d) in a concentration-dependent manner (Table S1). A
fraction of the Nrf2 was found in the perinuclear region after
Euk134 treatment, resulting in a distinctive perinuclear halo
(Fignal 5Ad). These results were not replicated using manganese-
tetrakis (4-benzoic acid) porphyrin (MnTBAP) to target superox-
ides (data not shown) pointing to a specific effect of hydrogen
peroxide in the Nrf2 mislocation.
We investigated nuclear Nrf2 translocation in Euk134-treated
frataxin-depleted fibroblasts in response to endogenous or
exogenous oxidative stress induced by oligomycin or tBHQ,
respectively. Nrf2 in Euk134-treated fibroblasts was found chiefly
in the cytosol under basal conditions (Figure 5Bd). Subjecting these
cells to oxidative stress resulted in massive nuclear translocation of
Nrf2 (Figure 5Be and f) with marked induction of the Phase II
antioxidants Sod2, glutathione reductase, and glutathione-S-
transferase (Figure 5C). Thus, the catalase mimetic Euk134 not
only relocalized Nrf2 to the actin stress filaments under basal
conditions, but also restored the responsiveness of the Nrf2
signaling pathway to superoxides generated by the respiratory
chain (oligomycin) or to cytosolic H2O2 (tBHQ). In keeping with
this, it has been recently shown that hydrogen peroxide scavenging
rescues frataxin deficiency in a Drosophila model of Friedreich’s
ataxia [39].
Next, we investigated two other approaches designed to restore
Nrf2 to its normal location in FRDA fibroblasts. First, we used
desferrioxamine or deferiprone for iron chelation (see Supple-
mental Text for experimental conditions). Both chelators rapidly
induced toxic effects, with early aconitase impairment. Neither
chelator substantially affected Nrf2 location under our experi-
mental conditions (Supplemental Table S1). Second, to decrease
the amount of intracellular peroxides, we provided either reduced
glutathione (10 mM) or its precursors N-acetyl cysteine (10 mM)
and reduced glutathione ethyl-ester (10 mM). Glutathione has
been reported to restore the actin filament network in FRDA cells
[21]. However, the actin network was not restored after 48 hours
of treatment, whereas Euk134 under similar conditions caused
rapid reorganization of the Nrf2 signaling pathway.
Discussion
Our results shed new light on the response of frataxin-depleted
FRDA cells to oxidative stress and provide a rational explanation
for the hypersensitivity of these cells to oxidative stress. First, we
showed that FRDA cells under basal conditions had a small but
consistent elevation in SOD activity and confirmed a reduction in
reduced glutathione, indicating that they had to cope with
abnormally high levels of superoxides and derived peroxides.
These data support the view that frataxin depletion places an
increased burden on several antioxidant defense mechanisms
under basal conditions. They challenge the recent suggestion [40]
that oxidative stress may not be involved in this disease.
Although the increased SOD activity and decreased pool of
reduced glutathione suggest increased peroxide production, the
antioxidant defense mechanisms of FRDA cells effectively handle
this challenge under basal conditions: the cells grow normally, show
no increase in apoptotic features, and exhibit normal aconitase
activity, which is an exquisitely sensitive marker for oxidative stress
[41]. The mechanism by which low frataxin content results in an
increased need for antioxidants under basal conditions does not
result from a defectinthe respiratory chain, which we found normal
in frataxin-depleted fibroblasts. Neither has a quantitative abnor-
mality in mitochondrial iron content been demonstrated in patient
fibroblasts so far. Qualitative abnormalities are however among the
predictable consequences of frataxin depletion with impaired iron
chaperoning leading to an increase in iron accessibility and intra
mitochondrial iron re location favoring iron reaction with oxygen.
Unfortunately, use of iron chelators does not provide a clue to test
for oxygen-associated iron toxicity [42]. We showed previously that,
although iron chelators protect biological membranes from iron-
Figure 3. Induction of phase II antioxidants mediated by Nrf2 in control and patient fibroblasts treated with tBHQ or oligomycin.
Transcription induced by tBHQ (A) or oligomycin (B). Significant differences were noted (*p,0.05 and **p,0.01). Values are means61 SEM.
Experimental procedures are described in the methods section.
doi:10.1371/journal.pone.0004253.g003
Faulty Nrf2 Signaling in FRDA
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oxidative reactions in the aqueous phase (prooxidant effect), thus
merely displacing the target of the oxidative process [43]. However,
a role of both oxygen [39,44] and iron [45,46] in determining the
consequences of frataxin depletion has been demonstrated in a
number of models and conditions suggesting that their interaction is
actually the critical factor.
Another finding from our study was disorganization of the Nrf2-
dependent phase II antioxidant-signaling pathway in FRDA cells
under basal conditions. The actin stress fibers were abnormal, as
previously reported [21], and we found that the Keap1 and Nrf2
proteins were not in their normal location bound to actin.
Induction of phase II antioxidants was absent or severely
decreased in response to endogenous and exogenous oxidative
stress. Disorganization of the Nrf2 pathway provides an explana-
tion for the impaired induction of antioxidants in response to
prooxidant compounds that has been found repeatedly in frataxin-
depleted cells. This disorganization was not ascribable to
Figure 4. Frataxin-depleted SKNAS cells. A. Anti-frataxin antibody produced strong mitochondrial labeling in control SKNAS cells (a) and
severely reduced labeling in SKNAS cells treated with frataxin-targeted shRNA (shRNAFra SKNAS cells) (b). B. Residual frataxin mRNA in patient
fibroblasts and shRNAFra SKNAS cells compared to control cells. C. Actin and Nrf2 in control (a, c, e, g) and shRNAFra (b, d, f, h) SKNAS cells under
basal conditions (a, b, c, d) or after tBHQ treatment (e, f, g, h). Actin staining with phalloidin (Phal) shows disorganization of the actin stress fibers in
shRNAFra SKNAS cells (a) compared to control SKNAS cells (b), in keeping with the results in fibroblasts. Nrf2 labeling produced similar abundant
staining of the cytoplasm of both control SKNAS cells (c) and shRNAFra SKNAS cells (d). Nuclear translocation of Nrf2 occurs in control SKNAS cells (e,
g) but not in shRNAFra SKNAS cells. D. Induction of Phase II antioxidants in SKNAS cells using oligomycin (a) or tBHQ (b). Significant differences were
noted (**p,0.01 and *** p,0.001). Values are means61 SEM. Experimental procedures are described in the methods section.
doi:10.1371/journal.pone.0004253.g004
Faulty Nrf2 Signaling in FRDA
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found that respiration was not different between FRDA fibroblasts
and control fibroblasts. Moreover, the restoration of the actin
filament network in FRDA cells treated with the catalase mimetic
Euk134 ruled out a role for abnormal ATP generation. We
recently reported marked activation of the Nrf2 pathway in
fibroblasts exhibiting an ATPase6 mutation responsible for
mitochondrial superoxide overproduction by the respiratory chain
[24]. A phosphoglycerate mutase (PGAM5) tethers a ternary
complex containing Keap1 and Nrf2 to the outer membrane of the
mitochondria [47], suggesting that a sub-pool of these proteins
might be required to trigger a cell response to mitochondrial
oxidative stress.
We found that induction of Phase II antioxidants differed after
oligomycin and tBHQ exposure. Thus, unknown factors may
determine which genes undergo increased transcription mediated
by Nrf2.
Frataxin is involved in ISC assembly, thereby regulating
mitochondrial iron handling and chaperoning [19]. Our results
establish that the Nrf2 pathway plays a crucial role in cells with
abnormal mitochondrial iron handling and chaperoning, i.e.,
frataxin- or Iscu-depleted cells. Interestingly, the hypersensitivity
to oxidative stress related to frataxin depletion antedated the
development of detectable decreases in iron-sulfur dependent
enzyme activities. We carefully investigated the cellular Grx2
content, since the Grx2 ISC may constitute a modular reservoir
that might have been affected by a partial and undetected
impairment of ISC synthesis. However, Grx2 was not decreased in
FRDA cells.
Obviously the existence of feedback-controlled loops between
prooxidant and antioxidant components that intimately links
oxygen to iron metabolism complicates the identification of the
initial step [8]. However, most of the evidence from this study and
the literature support a crucial role for hydrogen peroxide. Our
finding that a catalase mimetic restored the actin stress fibers and
oxidant-induced Nrf2 nuclear translocation in FRDA cells
established that hydrogen peroxide was among the early effectors
in the toxic cascade of oxidizing reactions. Accordingly, we failed
to restore Nrf2 nuclear translocation by activating downstream
components of the actin-Nrf2 signaling pathway, such as PI3
kinase or PKC. Similarly, recent results obtained using an FRDA
Drosophila model support a key role for hydrogen peroxide in the
abnormalities associated with frataxin depletion [39]. Finally, the
striking analogy between the cerebellar ataxia resulting from either
frataxin depletion or alcohol chronic ingestion suggests that a
similar H2O2-dependent actin remodeling hampering anti oxidant
defenses in a subset of sensory neurons might well be the actual
cause of the progressive cerebellar ataxia rather than the
genetically fixed ISP defect.
In conclusion, our findings suggest an explanation to the
hypersensitivity of FRDA cells to oxidative stress, known to be
partially counterbalanced in vivo by treatment with an antioxidant
such as idebenone [12,48]. Impairment of the Nrf2 signaling
pathway leads to failure of antioxidant induction in response to
oxidative stress (Figure 6) which suggests methods for restoring the
ability of frataxin-depleted cells to respond effectively to oxidative
stress. In keeping with this, ligand activation of PPARc
(Peroxisome Proliferator Activated Receptor) by the neuroprotec-
tive Pioglitazone, susceptible to increase cell antioxidant defenses
[49,50], may constitute one such method.
Materials and Methods
Cell culture
Cultured fibroblasts derived from forearm biopsies were taken
from four healthy controls and four patients with FRDA. Patients
and controls gave their written informed consent to the biopsy
procedure (this study was approved by the Conseil d’Ethique
Biome ´dicale de l’Institut de Recherches Robert Debre ´/Ir
2B). In
patient fibroblasts, the GAA expansion in the first intron of the
FRDA gene was larger than 2.1 kb on the shorter allele. The cells
were grown under standard conditions in Dulbecco modified
Eagle’s medium (DMEM; Gibco, Invitrogen, Cergy Pontoise,
France) supplemented with 10% fetal bovine serum, 10 g/ml
Figure 5. Effect of Euk134 on Nrf2 localization under basal
conditions and during oxidative stress in fibroblasts from
patients with Friedreich ataxia. A. Staining of actin (a,b) and Nrf2
(c,d) in untreated (a, c) and treated (200 mM Euk134 for 24 h) (b, d)
patient fibroblasts. Euk134 restored the normal actin network
organization and the location of Nrf2 on the actin bundles. B. Patient
fibroblasts under basal conditions (a, d), with oligomycin treatment (b,
e), or with tBHQ treatment (c, f) after 24 hours pretreatment with
200 mM Euk134 (d, e, f) or without pretreatment (a, b, c). In pre-treated
cells, oligomycin and tBHQ induced massive nuclear translocation of
Nrf2. C. Induction of Phase II antioxidants in control and patient
fibroblasts treated with oligomycin. Treatments and experimental
procedures are described in the methods section. Significant differenc-
es were noted (*p,0.05). Values are means61 SEM.
doi:10.1371/journal.pone.0004253.g005
Faulty Nrf2 Signaling in FRDA
PLoS ONE | www.plosone.org 7 January 2009 | Volume 4 | Issue 1 | e4253Figure 6. Diagram of the actin-Nrf2 signaling pathway in control and patient cells under basal conditions and during oxidative
stress. Under basal conditions, the Nrf2-Keap1 complex, or a sub-pool of it attached to the mitochondrial outer membrane by the PGAM5 protein, is
bound to the actin stress filament network of control cells. B. In frataxin-depleted cells, characterized by abnormal iron handling, the actin-Nrf2
signaling pathway is profoundly altered by the need to cope with elevated H2O2 levels. Removing H2O2 with the catalase mimetic Euk134 corrects
these alterations. C. Treating control cells with oligomycin or tBHQ results in major oxidative stress that destabilizes the actin-Nrf2-Keap1 complex,
leading to Nrf2 release and phosphorylation. Nuclear translocation of Nrf2 results in the recruitment of the co-activator(s) needed for Phase II
antioxidant transcription. D. In frataxin-depleted cells, the oxidative insult induced by oligomycin (endogenous) or tBHQ (exogenous) cannot be
counterbalanced by the induction of Phase II antioxidants, so that the cells are extremely sensitive to oxidation. Again, Euk134 treatment restores the
actin-Nrf2 signaling pathway, allowing transcription of Phase II antioxidants.
doi:10.1371/journal.pone.0004253.g006
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The medium was changed every three days.
Cell survival experiment
Cells were seeded in 6-well plates and grown to sub-confluence.
The effect on the cells of four days’ exposure to 30 mMo f
oligomycin was tested. The cells were counted after washing with
PBS and trypsination, using a Quick Read Precision Cell slide
(Globe Scientific Inc., Paramus, NJ).
Enzyme assays
SOD activity was measured using a Cary 50 UV–visible
spectrophotometer (Varian Inc, Les Ulis, France). Activities were
determined by monitoring pyrogallol autooxidation at 420 nm
and expressed as IU/mg protein. Protein concentrations were
measured according to Bradford [51].
Glutathione measurements
Glutathione levels were determined using a variant of the
recycling enzymatic assay [52]. To estimate intracellular glutathi-
one, total proteins were extracted with RIPA buffer. The assay
reaction mixture was composed of cell extract, 20 mM DTNB,
and 10 mM NADPH in 50 mM potassium phosphate buffer,
pH 7.8. The reaction was started by adding glutathione reductase
(1.5 units/ml), and the kinetics of DTNB conversion to TNB was
followed spectrophotometrically at 412 nm. Glutathione concen-
trations were calculated from standard curves obtained with
various concentrations of reduced glutathione (GSH) and oxidized
glutathione (GSSG), based on the rates of TNB formation. For
GSSG quantification, samples were pre-treated with 5% (v/v) 2-
vinylpyridine for 1 hour at room temperature before analysis.
Polarography
Respiration of intact cells and oxidation of mitochondrial
substrate (using 0.006% digitonin-permeabilized cells) were esti-
mated using polarography, in a magnetically-stirred 250-ml cell
thermostated at 37uC (DW1 Clark oxygen electrode; Hansatech
Instruments; Norfolk, UK) [53]. All chemicals were of the purest
grade available from Sigma–Aldrich (St Quentin; Falavier, France).
Immunofluorescent staining
Fibroblasts washed with PBS were fixed with 4% paraformalde-
hyde for 20 min, permeabilized with 0.1% Triton X-100 (w/v) for
5 min, and washed three times with PBS. After blocking with 5%
goat serum in PBS/0.05% Tween (v/v) for 30 min, the cells were
treated with anti-frataxin antibody, anti-Nrf2 antibody, anti-Keap1
antibody (all diluted 50-fold), or Alexa 568-conjugated phalloidin
(diluted 250-fold), for 2 h. The cells were washed three times with
PBS/0.05% Tween then treated with anti-rabbit or anti-mouse
secondary antibody (diluted 500-fold) for 1 hour. The cells were then
washed three times in PBS/0.05% Tween and mounted with
fluorescent mounting medium (Dako, Trappes, France). All the
procedures were carried out at room temperature. Antibodies to Nrf2
(H300), Keap1 (E-20), and frataxin (H-155) were purchased from
Santa Cruz Biotechnology (Heidelberg, Germany). Alexa 568-
conjugated phalloidin and Alexa 488-conjugated anti-rabbit second-
ary antibody were from Invitrogen (Cergy Pontoise, France).
Fluorescent microscopy was performed using an LSM5 Exciter
microscope (Zeiss; Le Pecq, France) and images were acquired using
Axiovision software.
Treatment with oligomycin, tBHQ, and Euk134
Oxidative stress was induced by exposing the cells to oligomycin
(30 mM; 18 h) or tertiary-butylhydroquinone (tBHQ) (100 mM;
20 h) (Sigma; St Quentin Falavier, France). The cells were then
prepared for immunofluorescence staining or harvested for
Western blot analysis or total RNA extraction. Oligomycin and
tBHQ were diluted in ethanol. The final concentration of ethanol
never exceeded 0.2%. To test for cellular H2O2 role in the FRDA
cell phenotype, cells were treated with Euk134 (200 mM; 24 h)
(Cayman Europe; Tallinn, Estonia) diluted in dimethyl sulfoxide
(DMSO), whose final concentration did not exceed 0.1%.
Western blot experiments
The cytoplasmic and nuclear fractions of fibroblasts were
obtained using the NXTRACT kit (Sigma-Aldrich; St Quentin
Falavier, France), according to the manufacturer’s instructions,
except that lauryl-maltosyl (4 mM final concentration) was used as
a detergent instead of IGEPAL-CA-630 during cell disruption.
The protein concentration was assessed according to Bradford.
Samples were heated for 5 min at 95uC with b-mercapto-ethanol,
and SDS PAGE Western blotting was performed using standard
techniques. Either 40 or 60 mg of protein was loaded on 10%
acrylamide gel then transferred to a PVDF membrane (Biorad,
Marnes-la-Coquette, France). The membranes were blocked in
5% skim milk in PBS/0.05% Tween and incubated overnight with
primary antibodies, at 4uC). Anti-GAPDH (ab8245) and anti-
histone H1 (ab11079) antibodies were purchased from Abcam
(Paris, France). HRP secondary antibodies (1 h RT) were revealed
by ECL (Amersham Pharmacia Biotech, Amersham, UK).
Densitometric measures were performed with Image J software.
Q-PCR experiments
Total RNA was extracted from fibroblasts using the RNeasyHMini
Kit (Qiagen; Courtaboeuf, France) and cDNA was obtained from
1 mg RNA using the RNA PCR Core kit (Roche; Neuilly sur Seine,
France) according to the manufacturer’s instructions. Quantitative
PCR was performed using IQ
tmSYBRH Green supermix and the
MyIQ Single-Color Real-Time PCR Detection System (Biorad).
Amplification was achieved using 3 minutes’ denaturation at 95uC,
45 denaturation cycles at 96uCf o r2 0s ,a n n e a l i n ga t6 0 uCf o r2 0s ,
elongation at 72uC for 20 s, melting at 95uC for 1 min then 55uCf o r
1m i n ,a n dh e a t i n gt o9 5 uC. RNA was used as the template for the
negative-control amplifications included in each PCR run. All
reactions were performed in triplicate, and PCR runs were repeated
twice. Data were analyzed using MyIQH software. The amount of
target mRNA was normalized for the HPRT gene mRNA. Primer
pairs were designed to be 20 bp in various exons and to generate
products of about 100 bp. Primers were as follows: HPRT,
59GGTGAAAAGGACCCCACGA39 and 59TCAAGGGCA-
TATCCTACAACA39;N Q O 1 ,5 9CATTCTGAAAGGCTGGT-
TTGA39and 59TTGCAGAGAGTACATGGAGC39;S O D 1 ,
59TTGGGCAAAGGTGGAAATGAA39and 59CACCACAAGC-
CAAACGACTT39;S O D 2 ,5 9GGACAAACCTCAGCCCTAA-
CG39 and 59TTTGATGGCTTCCAGCAACTC39;G S T P 1 ,
59GCAGGAGGGCTCACTCAAA39 and 59AGGTGACGCAG-
GATGGTATT39; GCLC, 59TGCTGTCTTGCAGGGAATGT39
and 59CACAACCATCCACCACTGC39;c a t a l a s e ,5 9GTCTG-
TGTGAGAACATTGCC39 and 59ATGTGGCTCCCGTAGT-
CAG39; glutathione reductase, 59ATCCCAACTGTGGTCTT-
CAG39 and 59CACGTTGAATAGGTC TTCACA39; and frataxin,
59CCCAGGCTCTCTAGATGAG39 and 59GTCCAGTCA-
TAACGCTTAGG39.
Short hairpin RNA experiments
Neuroblastoma-derived SKNAS cells were used after frataxin
silencing by short hairpin RNA (shRNA). In brief, frataxin-
depleted SKNAS cells were obtained by transducing lentiviral
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puromycin resistance cassette (MISSION
TM TRC shRNA;
Sigma-Aldrich, St Louis, Missouri). The frataxin-targeting se-
quence of shRNA was CCGGGCTGGACTCTTTAGCA-
GAGTTCTCGAGAACTCTGCTAAAGAGTCCAGCTTTTT.
SKNAS cells were seeded in 24-well plates. After 24 h, 2 mg/ml
hexadimethrine bromide was added just before infection with
lentiviral particles. After 18 h, the cells were washed three times
with PBS. Successfully infected cells were selected using 10 mg/ml
of puromycin (15 d).
Statistical analysis
Data are reported as means6SEM. Statistical tests were run
using Statview software (SAS, Cary, NC). ANOVA was per-
formed, followed by Student’s test.
Supporting Information
Figure S1 Samples were loaded as following: controls (lanes 1, 2
and 3), patients (lane 4, 5 and 6), purified Grx2 (lane 7). a-actin
was used as a loading control.
Found at: doi:10.1371/journal.pone.0004253.s001 (2.18 MB TIF)
Table S1 Effect of iron chelators and Euk134 on Nrf2
localization in control and patient fibroblasts. Control and patient
cells were exposed 24 h either to Deferiprone, Desferoxamine or
Euk134. Results reflect percentage of cells showing actin-bound
Nrf2.
Found at: doi:10.1371/journal.pone.0004253.s002 (0.04 MB
DOC)
Text S1 Supplemental Experimental Procedures and figure
legend
Found at: doi:10.1371/journal.pone.0004253.s003 (0.03 MB
DOC)
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